Is EA's Partnership With Stability AI Set to Reshape Content Creation and Profitability?

• On October 23, 2025, Electronic Arts announced a partnership with Stability AI to co-develop generative AI models, tools, and workflows designed to empower EA’s artists, designers, and developers in the game creation process.
• This collaboration marks one of the gaming industry's significant investments in generative technology, aiming to accelerate content production and elevate creative possibilities for world-class games.
• We’ll examine how the introduction of generative AI tools could influence EA’s future efficiency and long-term profitability outlook.

Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Electronic Arts Investment Narrative Recap

To be a shareholder in Electronic Arts, you need to believe that the company's investments in cutting-edge technologies, like generative AI, will pay off by driving player engagement and boosting its live services portfolio amidst a rapidly shifting gaming industry. While the new partnership with Stability AI could contribute to long-term efficiency, it does not have a material impact on the core short-term catalyst, which remains the successful performance and monetization of key franchises; at the same time, execution risk around live service revenue, particularly the decline in Apex Legends bookings, stands out as the most significant concern right now.

Among recent developments, EA’s report of lower sales and earnings for the latest quarter is especially relevant when considering the potential payoff of new technology investments. The company's declining net income and EPS highlight the pressure to counteract weaknesses in existing revenue streams with innovative content and more efficient development, areas where the expected benefits of generative AI integration will be closely monitored as shareholders assess near-term results against ongoing risks.

On the other hand, investors should also be aware that extended weakness in live service revenue could...

Read the full narrative on Electronic Arts (it's free!)

Electronic Arts' outlook anticipates $8.7 billion in revenue and $1.6 billion in earnings by 2028. Achieving this milestone requires 5.1% annual revenue growth and a $0.6 billion earnings increase from the current $1.0 billion.

Uncover how Electronic Arts' forecasts yield a $193.88 fair value, a 3% downside to its current price.

Exploring Other Perspectives

Six fair value estimates from the Simply Wall St Community span US$120.39 to US$193.88 per share, showcasing a broad range of individual outlooks. Some see underappreciated growth potential, but with live service revenue volatility, perspectives on EA's future performance are far from uniform, explore several opinions to inform your view.

Explore 6 other fair value estimates on Electronic Arts - why the stock might be worth as much as $193.88!

Build Your Own Electronic Arts Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Electronic Arts research is our analysis highlighting 1 key reward that could impact your investment decision.
• Our free Electronic Arts research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Electronic Arts' overall financial health at a glance.

Ready For A Different Approach?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Outshine the giants: these 26 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The end of cancer? These 27 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com